97精品国产自-97精品国产自产-97精品国产综合久久-97精品久-97精品免费视频-97精品人人

廚房設備網
手機版
首頁> 資訊>政策法規> 正文

(EU) No 2015/1492:就乙酰異戊酰泰樂菌素,修訂法規(EU) No 37/2010附錄

發布時間:2017-05-02 09:35:41   發布人: 互聯網    點擊數:566  

COMMISSION IMPLEMENTING REGULATION (EU) 2015/1492     of 3 September 2015     amending Regulation (EU) No 37/2010 as regards the substance ‘tylvalosin’     (Text with EEA relevance)     THE EUROPEAN COMMISSION,     Having regard to the Treaty on the Functioning of the European Union,     Having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council (1), and in particular Article 14 in conjunction with Article 17 thereof,     Having regard to the opinion of the European Medicines Agency formulated by the Committee for Medicinal Products for Veterinary Use,     Whereas:     (1)     Article 17 of Regulation (EC) No 470/2009 requires that the maximum residue limit (hereinafter ‘MRL’) for pharmacologically active substances intended for use in the Union in veterinary medicinal products for food-producing animals or in biocidal products used in animal husbandry is established in a regulation.     (2)     Table 1 of the Annex to Commission Regulation (EU) No 37/2010 (2) sets out the pharmacologically active substances and their classification regarding MRLs in foodstuffs of animal origin.     (3)     Tylvalosin is currently included in that table as an allowed substance, for porcine and poultry species, applicable to muscle, skin and fat, liver and kidney in porcine species and to skin and fat and liver in poultry species, excluding animals producing eggs for human consumption.     (4)     An application for the extension of the existing entry for tylvalosin to chicken eggs has been submitted to the European Medicines Agency (hereinafter ‘EMA’).     (5)     The EMA, based on the opinion of the Committee for Medicinal Products for Veterinary Use has recommended the establishment of a MRL for chicken eggs.     (6)     According to Article 5 of Regulation (EC) No 470/2009 the EMA is to consider using MRLs established for a pharmacologically active substance in a particular foodstuff for another foodstuff derived from the same species, or MRLs established for a pharmacologically active substance in one or more species for other species.     (7)     The EMA has considered that the extrapolation of the MRLs for tylvalosin from chicken eggs to eggs of other poultry species is appropriate.     (8)     Regulation (EU) No 37/2010 should therefore be amended accordingly.     (9)     It is appropriate to grant the stakeholders concerned a reasonable period of time to take measures that may be required to comply with the new MRL.     (10)     The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,     HAS ADOPTED THIS REGULATION:     Article 1     The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.     Article 2     This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.     It shall apply from 3 November 2015.     This Regulation shall be binding in its entirety and directly applicable in all Member States.     Done at Brussels, 3 September 2015.     For the Commission     The President     Jean-Claude JUNCKER     (1)  OJ L 152, 16.6.2009, p. 11.     (2)  Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (OJ L 15, 20.1.2010, p. 1).     ANNEX     In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘tylvalosin‘ is replaced by the following:
   

harmacologically active substance

Marker residue

Animal species

MRL

Target tissues

Other provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic classification

‘Tylvalosin

Tylvalosin

orcine

50 μg/kg

50 μg/kg

50 μg/kg

50 μg/kg

Muscle

kin and fat

Liver

Kidney

O ENTRY

Anti-infectious agents/Antibiotics’

oultry

200 μg/kg

Eggs

um of Tylvalosin and 3-0-acetyltylosin

oultry

50 μg/kg

50 μg/kg

kin and fat

Liver

免責聲明:本網站所收集的部分公開資料來源于互聯網,轉載的目的在于傳遞更多信息及用于網絡分享,并不代表本站贊同其觀點和對 其真實性負責,也不構成任何其他建議。如果您發現網站上有侵犯您的知識產權的作品,請與我們取得聯系,我們會及時修改或刪除。

同類資訊

推薦資訊 更多
點擊排行

版權所有:廚聯科技 (c)2008-2022 CFSBCN All Rights Reserved

客戶服務郵箱:350319542@cfsbcn.com 郵編:610000 蜀ICP備14006818號-4 聯系電話:13880215230

成都地址:成都高新區府城大道西段399天府新谷10號樓17F

主站蜘蛛池模板: 国产免费无码午夜福利电影 | 99久久综合久中文 | 国产成人av大片在线播放 | 91精品国产一区自在线拍 | 人妻无码一区二区视频观看 | 精品人妻少妇嫩草av无 | 精品一区二区三区影院在线 | 国产成人午夜福利在线观看视频 | 欧美亚洲中文精品三区 | 国产91精品福利在线观看 | 成人h动漫精品一区二区无 成人h动漫精品一区二区无码 | 97人妻天 | 国产亚洲精品久久久久久国模美 | 无码人妻a一区二区三区色戒乐 | 国产99久久亚洲综合网 | 亚洲一区高清 | 亚洲AV国产成人精品区三上 | 91极品尤物| 国产成人刺激视频在线观看 | 成人国产一区二区精品小说 | 久久久久综合一本久道 | 国产成人av每日更新 | 国产精品成人影院在 | 久久黄色小视频 | 少妇人妻偷人精品无码av | 国产精品麻豆成人av电影艾秋 | 国产成人片aⅴ在线观看 | 四虎影视在线影院在线观看 | av无码三级片在线播放 | 国产精品无码av在线播放不 | 久久久精品久久久久久 | 欧美精品久久96人妻无码 | 久久免费看少妇高潮A片2012 | japanese厨房乱tub偷| 国产精品视频福利一区二区 | 亚洲A片无码一区二区蜜桃 亚洲A片无码一区二区蜜桃久久 | 欧美XXXXX高潮喷水麻豆 | 国产综合久久久久鬼色 | 91精品乱码一区 | 一区二区三区不卡视屏 | 李宗瑞完整版种子 |